Search

Agrawal, Pankaj, Corinne Strickland, Charles Midgett, Ana Morales, Daniel Newburger, Melisa Poulos, Kinga Tomczak, et al. 2004. “Heterogeneity of Nemaline Myopathy Cases With Skeletal Muscle Alpha-Actin Gene Mutations.”. Ann Neurol 56 (1): 86-96.

Sanoudou, Despina, Peter Kang, Judith Haslett, Mei Han, Louis Kunkel, and Alan Beggs. 2004. “Transcriptional Profile of Postmortem Skeletal Muscle.”. Physiol Genomics 16 (2): 222-8.

Yang, Nan, Daniel Macarthur, Jason Gulbin, Allan Hahn, Alan Beggs, Simon Easteal, and Kathryn North. 2003. “ACTN3 Genotype Is Associated With Human Elite Athletic Performance.”. Am J Hum Genet 73 (3): 627-31.

Nimgaonkar, Ashish, Despina Sanoudou, Atul Butte, Judith Haslett, Louis Kunkel, Alan Beggs, and Isaac Kohane. 2003. “Reproducibility of Gene Expression across Generations of Affymetrix Microarrays.”. BMC Bioinformatics 4: 27.

Ryan, Ilkovski, Strickland, Schnell, Sanoudou, Midgett, Houston, et al. 2003. “Clinical Course Correlates Poorly With Muscle Pathology in Nemaline Myopathy.”. Neurology 60 (4): 665-73.

Wattanasirichaigoon, Swoboda, Takada, Tong, Lip, Iannaccone, Wallgren-Pettersson, Laing, and AH Beggs. 2002. “Mutations of the Slow Muscle Alpha-Tropomyosin Gene, TPM3, Are a Rare Cause of Nemaline Myopathy.”. Neurology 59 (4): 613-7.

Nowak, Wattanasirichaigoon, Goebel, Wilce, Pelin, Donner, Jacob, et al. 1999. “Mutations in the Skeletal Muscle Alpha-Actin Gene in Patients With Actin Myopathy and Nemaline Myopathy.”. Nat Genet 23 (2): 208-12.

Satler, Vesely, Duggal, Ginsburg, and AH Beggs. 1998. “Multiple Different Missense Mutations in the Pore Region of HERG in Patients With Long QT Syndrome.”. Hum Genet 102 (3): 265-72.

Wyszynski, Lin, Rao, Nigh, AH Beggs, Craig, and Sheng. 1997. “Competitive Binding of Alpha-Actinin and Calmodulin to the NMDA Receptor.”. Nature 385 (6615): 439-42.

North, Miller, Iannaccone, Clemens, Chad, Bella, Smith, AH Beggs, and Specht. 1996. “Cognitive Dysfunction As the Major Presenting Feature of Becker’s Muscular Dystrophy.”. Neurology 46 (2): 461-5.